Dose-Painted Intensity Modulated Radiotherapy Pancreas (DP-IMRT Pancreas)

Recruiting Phase 1 Phase 2 Interventional Study
Pancreatic Adenocarcinoma
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Trial phase
Phase 1/2
Study type
Interventional
Purpose
Treatment
Participants needed
49 (estimated)
Sponsor
Cancer Trials Ireland · Research network
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This is a prospective non-randomised Phase I/II Radiotherapy (RT) study with patients recruited to escalated dose cohorts. Patients with resectable or borderline resectable (per the National Comprehensive Cancer Network (NCCN) criteria) pancreatic adenocarcinoma will receive dose-escalated hypofractionated DP-IMRT via Intensity Modulated Radiotherapy (IMRT) / Volume Modulated Arc Therapy (VMAT).

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria 1. Written informed consent obtained prior to any study-related procedures 2. Age ≥18 years 3. ECOG (European Cooperative Oncology Group) performance status (PS) 0-2 4. Resectable or borderline resectable per National Comprehensive Cancer Network (NCCN) criteria (see Appendix H) …
Contacts

Cancer Trials Ireland

+35316677211

info@cancertrials.ie

CONTACT